1.Torres, AR, Lima, MC. Epidemiology of obsessive-compulsive disorder: a review. [Portuguese] Rev Bras Psiquatr. 2005;27:237–242.
2.Fontenelle, LF, Mendlowicz, MV, Versiani, M. The epidemiological of obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. In press.
3.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association: 1994.
4.World Health Organization. The International Classification of Diseases. 10th ed. Geneva, Switzerland: World Health Organization; 1992.
5.Summerfeldt, LJ, Richter, MA, Antony, MM, Swinson, RP. Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther. 1999;37:297–311.
6.Mataix-Cols, D, Rosario-Campos, MC, Leckman, JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005;162:228–238.
7.Miguel, EC, Leckman, JF, Rauch, S, et al.Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry. 2005;10:258–275.
8.Hantouche, EG, Lancrenon, S. Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients [French]. Encephale. 1996;22:9–21.
9.Mataix-Cols, D. Deconstructing obsessive-compulsive disorder: a multidimensional perspective. Curr Opin Psychiatry. 2006;19:84–89.
10.Insel, TR. Phenomenology of obsessive-compulsive disorder. J Clin Psychiatry. 1990;51:4–8.
11.Steketee, GS, Grayson, JB, Foa, EB. Obsessive-compulsive disorder: differences between washers and checkers. Behav Res Ther. 1985;23:197–201.
12.Calamari, JE. Understanding the heterogeneity of OCD. Am J Psychiatry. 2005;162:2193–2194.
13.Rosen, M. A dual model of obsessional neurosis. J Consult Clin Psychol. 1975;43:453–459.
14.Lima, MA. Responsabilidade e fragilidade: contribuição ao estudo da psicopatologia fenomenológica do transtorno obsessivo-compulsivo [dissertation]. São Paulo, Brazil: São Paulo Medical School; 1994.
15.Rasmussen, SA, Eisen, JL. The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry. 1994;55(supl 10):5–10.
16.Attiullah, N, Eisen, JL, Rasmussen, SA. Clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:469–491.
17.Insel, TR, Akiskal, HS. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry. 1986;143:1527–1533.
18.Lee, HJ, Kwon, SM. Two different types of obsessions: autogenous and reactive obsessions. Behav Res Ther. 2003;41:11–29.
19.Perugi, G, Akiskal, HS, Gemignani, A, et al.Episodic course of obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 1998;248:240–244.
20.Hasler, G, LaSalle-Ricci, V, Ronquillo, JG, et al.Obsessive-compulsive disorder dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res. 2005;135:121–132.
21.Fontenelle, LF, Mendlowicz, MV, Kalaf, J, Domingues, AM, Versiani, M. Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive-compulsive disorder? Int Clin Psychopharmacol. 2005;20:343–346.
22.Grant, JE, Mancebo, MC, Pinto, A, Eisen, JL, Rasmussen, SA. Impulse control disorders in adults with obsessive-compulsive disorder. J Psychiatr Res. 2006;40:494–501.
23.Leckman, JF, Grice, DE, Barr, LC, et al.Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety. 1994–1995;1:208–215.
24.Miguel, EC, Coffey, BJ, Baer, L, Savage, CR, Rauch, SL, Jenike, MA. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 1995;56:246–255.
25.Miguel, EC, Rauch, SL, Jenike, MA. Obsessive-compulsive disorder. Psychiatr Clin North Am. 1997;20:863–883.
26.Miguel, EC, do Rosario-Campos, MC, Shavitt, RG, Hounie, AG, Mercadante, MT. The tic-related obsessive-compulsive disorder phenotype and treatment implications. Adv Neurol. 2001;85:43–55.
27.Sobin, C, Blundell, ML, Karayiorgou, M. Phenotypic differences in early- and lateonset obsessive-compulsive disorder. Compr Psychiatry. 2000;41:373–379.
28.Rosario-Campos, MC, Leckman, JF, Mercadante, MT, et al.Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158:1899–1903.
29.Fontenelle, LF, Mendlowicz, MV, Marques, C, Versiani, M. Early- and late-onset obsessive-compulsive disorder in adult patients: an exploratory clinical and therapeutic study. J Psychiatr Res. 2003;37:127–133.
30.Millet, B, Kochman, F, Gallarda, T, et al.Phenomenological and comorbid features associated in obsessive–compulsive disorder: influence of age of onset. J Affect Disord. 2004;79:241–246.
31.McKay, D, Abramowitz, JS, Calamari, JE, et al.A critical evaluation of obsessive compulsive disorder subtypes: symptoms versus mechanisms. Clin Psychol Rev. 2004;24:283–313.
32.Leckman, JF, Goodman, WK, Anderson, GM, et al.Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995;12:73–86.
33.Diniz, JB, Rosario-Campos, MC, Hounie, AG, et al.Chronic tics and Tourette syndrome in patients with obsessive–compulsive disorder. J Psychiatr Res. 2006;40:487–493.
34.Holzer, JC, Goodman, WK, McDougle, CJ, et al.Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry. 1994;164:469–473.
35.do Rosario-Campos, MC, Leckman, JF, Curi, M, et al.A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2005;136:92–97.
36.Coffey, BJ, Miguel, EC, Biederman, J, et al.Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis. 1998;186:201–206.
37.Diniz, JB, Rosario-Campos, MC, Shavitt, RG, et al.Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. J Clin Psychiatry. 2004;65:22–27.
38.Pauls, DL, Leckman, JF, Towbin, KE, Zahner, GE, Cohen, DJ. A possible genetic relationship exists between Tourette's syndrome and obsessive-compulsive disorder. Psychopharmacol Bull. 1986;22:730–733.
39.Pauls, DL, Raymond, CL, Steverson, JM, Leckman, JF. A family study of Gilles de la Tourette syndrome. Am J Hum Genet. 1991;48:154–163.
40.Comings, DE, Comings, BG. Hereditary agoraphobia and obsessive-compulsive behaviour in relatives of patients with Gilles de la Tourette's syndrome. Br J Psychiatry. 1987;151:195–199.
41.Robertson, MM, Trimble, MR, Lees, AJ. The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br J Psychiatry. 1988;152:383–390.
42.Pauls, DL, Leckman, JF. The inheritance of Gilles de la Tourette's syndrome and associates behaviors. Evidence for autosomal dominant transmission. N Engl J Med. 1986;315:993–997.
43.Eapen, V, Pauls, DL, Robertson, MM. Evidence for autosomal dominant transmission in Tourette's syndrome. United Kingdom cohort study. Br J Psychiatry. 1993;162:593–596.
44.Leonard, HL, Swedo, SE, Lenane, MC, et al.A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry. 1993;50:429–439.
45.Pauls, DL, Alsobrook, JP 2nd, Goodman, W, Rasmussen, S, Leckman, JF. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;152:76–84.
46.Grados, MA, Riddle, MA, Samuels, JF, et al.The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol Psychiatry. 2001;50:559–565.
47.Hanna, GL, Himle, JA, Curtis, GC, Gillespie, BW. A family study of obsessive-compulsive disorder with pediatric probands. Am J Med Genet B Neuropsychiatr Genet. 2005;134:13–19.
48.Nicolini, H, Cruz, C, Camerena, B, et al.DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry. 1996;1:461–465.
49.Cruz, C, Camarena, B, King, N, et al.Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci Lett. 1997;231:1–4.
50.Millet, B, Chabane, N, Delorme, R, et al.Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2003;116:55–59.
51.Abelson, JL, Curtis, GC, Sagher, O, et al.Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry. 2005;57:510–516.
52.Rauch, SL, Dougherty, DD, Shin, LM, et al.Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectr. 1998;3:37–43.
53.Saxena, S, Brady, AL, Schwartz, JM, Baxter, LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(suppl)35:26–37.
54.Busatto, GF, Zamignani, DR, Buchpiguel, CA, et al.A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 2000;99:15–27.
55.Scarone, S, Colombo, C, Livian, S, et al.Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res. 1992;45:115–121.
56.Robinson, D, Wu, H, Munne, RA, et al.Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:393–398.
57.Szeszko, PR, Robinson, D, Alvir, JM, et al.Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry. 1999;56:913–919.
58.Rosenberg, DR, Keshavan, MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry. 1998;43:623–640.
59.Szeszko, PR, MacMillan, S, McMeniman, M, et al.Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry. 2004;161:1049–1056.
60.Choi, JS, Kang, DH, Kim, JJ, et al.Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder. J Psychiatr Res. 2004;38:193–199.
61.Swedo, SE, Schapiro, MB, Grady, CL, et al.Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46:518–523.
62.Baxter, LR Jr. Phelps, ME, Mazziotta, JC, Guze, BH, Schwartz, JM, Sellin, CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44:211–218.
63.Busatto, GF, Buchpiguel, CA, Zamignani, DR, et al.Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study. J Am Acad Child Adolesc Psychiatry. 2001;40:347–354.
64.Peterson, B, Riddle, MA, Cohen, DJ, et al.Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology. 1993;43:941–949.
65.Baumgardner, TL, Singer, HS, Denckla, MB, et al.Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology. 1996;47:477–482.
66.Mostofsky, SH, Wendlandt, J, Cutting, L, Denckla, MB, Singer, HS. Corpus callosum measurements in girls with Tourette syndrome. Neurology. 1999;53:1345–1347.
67.Eidelberg, D, Moeller, JR, Antonini, A, et al.The metabolic anatomy of Tourette's syndrome. Neurology. 1997;48:927–934.
68.Stern, E, Silbersweig, DA, Chee, KY, et al.A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry. 2000;57:741–748.
69.Baxter, LR. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. J Clin Psychiatry. 1990;51(suppl):22–5; discussion 26.
70.Peterson, B, Zhang, H, Anderson, GM, Leckman, JF. A double-blind, placebo-controlled, crossover trial of an antiadrogen in the treatment of Tourette's syndrome. J Clin Psychopharmacol. 1998;18:324–331.
71.Himle, JA, Fisher, DJ, Van Etten, ML, Janeck, AS, Hanna, GL. Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder. Depress Anxiety. 2003;17:73–77.
72.McDougle, CJ, Goodman, WK, Leckman, JF, Barr, LC, Heninger, GR, Price, LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993;13:354–358.
73.McDougle, CJ, Goodman, WK, Leckman, JF, Lee, NC, Heninger, GR, Price, LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302–308.
74.Minichiello, WE, Baer, L, Jenike, MA. Schizotypal personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder. J Anxiety Disord. 1987;1:273–276.
75.McDougle, CJ, Goodman, WK, Price, LH, et al.Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990;147:652–654.
76.Baer, L, Jenike, MA, Black, DW, Treece, C, Rosenfeld, R, Greist, J. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:862–866.
77.Alarcon, RD, Libb, JW, Spitler, D. A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol. 1993;13:210–213.
78.Winsberg, ME, Cassic, KS, Koran, LM. Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry. 1999;60:591–597.
79.Erzegovesi, S, Cavallini, MC, Cavedini, P, Diaferia, G, Locatelli, M, Bellodi, L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol. 2001;21:488–492.
80.Alonso, P, Menchon, JM, Pifarre, J, et al.Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry. 2001;62:535–540.
81.Shavitt, RG, Belotto, C, Curi, M, et al.Clinical features associated with treatment response in obsessive-compulsive disorder. Compr Psychiatry. 2006;47:276–281.
82.Ferrao, YA, Shavitt, RG, Bedin, NR, et al.Clinical features associated to refractory obsessive-compulsive disorder. J Affect Disord. 2006;94:199–209.
83.Miguel, EC, Shavitt, RG, Ferrao, YA, Brotto, SA, Diniz, JB. How to treat OCD in patients with Tourette syndrome. J Psychosom Res. 2003;55:49–57.
84.Hounie, AG, Pauls, DL, do Rosario-Campos, MC, et al.Obsessive-compulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry. 2006 Apr 7: [Epub ahead of print].
85.Saxena, S, Wang, D, Bystritsky, A, Baxter, LR Jr. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry. 1996;57:303–306.
86.Hemmings, SM, Kinnear, CJ, Lochner, C, et al.Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatry Res. 2004;128:175–182.
87.Chabane, N, Delorme, R, Millet, B, Mouren, MC, Leboyer, M, Pauls, D. Early-onset obsessive-compulsive disorder: a subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry. 2005;46:881–887.
88.Geller, D, Biederman, J, Jones, J, et al.Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of pediatric literature. J Am Acad Child Adolesc Psychiatry. 1998;37:420–427.
89.Albert, U, Picco, C, Maina, G, Forner, F, Aguglia, E, Bogetto, F. Phenomenology of patients with early and adult onset obsessive-compulsive disorder [Portuguese]. Epidemiol Psichiatr Soc. 2002;11:116–126.
90.Delorme, R, Goldmard, JL, Chabane, N, et al.Admixture analisis of age of onset in obsessive-compulsive disorder. Psychol Med. 2005;35:237–243.
91.Nestadt, G, Samuels, J, Riddle, M, et al.A family study of obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57:573–580.
92.Chacon, PJ, Rosario, MC, Pauls, DL, et al.Obsessive-compulsive symptom dimension in sibling pairs diagosed with obsessive-compulsive disorder. Am J Med Genet. In press.
93.Hanna, GL, Veenstra-VanderWeele, J, Cox, NJ, et al.Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114:541–552.
94.Veenstra-VanderWeele, J, Kim, SJ, Gonen, D, Hanna, GL, Leventhal, BL, Cook, EH Jr. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol Psychiatry. 2001;6:160–167.
95.Denys, D, Van Nieuweburgh, F, Deforce, D, Westenberg, H. Association between the dopamine D2 receptor Taql A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol. 2006;16:446–450.
96.Denys, D, Van Nieuweburgh, F, Deforce, D, Westenberg, H. Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord. 2006;91:39–44.
97.Rosenberg, DR, Keshavan, MS, O'Hearn, KM, et al.Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry. 1997;54:824–830.
98.Ackerman, DL, Greenland, S, Bystritsky, A, Morgenstern, H, Katz, RJ. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol. 1994;14:247–254.
99.Ravizza, L, Barzega, G, Bellino, S, Bogetto, F, Maina, G. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:368–373.
100.Ackerman, DL, Greenland, S, Bystritsky, A. Side effects as predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol. 1999;19:459–465.
101.Shetti, CN, Reddy, YC, Kandavel, T, et al.Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry. 2005;66:1517–1523.
102.Ackerman, DL, Greenland, S, Bystritsky, A. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol. 1998;18:185–192.
103.Swedo, SE, Leonard, HL, Schapiro, MB, et al.Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics. 1993;91:706–713.
104.Asbahr, FR, Negrao, AB, Gentil, V, et al.Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry. 1998;155:1122–1124.
105.Mercadante, MT, Busatto, GF, Lombroso, PJ, et al.The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000;157:2036–2038.
106.Mercadante, MT, Diniz, JB, Hounie, AG, et al.Obsessive-compulsive spectrum disorders in rheumatic fever patients. J Neuropsychiatry Clin Neurosci. 2005;17:544–547.
107.Alvarenga, , Miguel, EC, Ana, AG, et al.Obsessive-compulsive symptoms in adults with non-active rheumatic fever. J Neuropsychiatry Clin Neurosci. In press.
108.Hounie, AG, Pauls, DL, Mercadante, MT, et al.Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydeham's chorea. J Clin Psychiatry. 2004;65:994–999.
109.Swedo, SE, Leonard, HL, Garvey, M, et al.Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–271.
110.Singer, HS. PANDAS and immunomodulatory therapy. Lancet. 1999;354:1137–1138.
111.Singer, HS, Hong, JJ, Yoon, DY, Williams, PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology. 2005;65:1701–1707.
112.Lougee, L, Perlmutter, SJ, Nicolson, R, Garvey, MA, Swedo, SE. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry. 2000;39:1120–1126.
113.Garvey, MA, Perlmutter, SJ, Allen, AJ, et al.A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45:1564–1571.
114.Snider, LA, Lougee, L, Slaterry, M, Grant, P, Swedo, SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005;57:788–792.
115.Gilbert, D, Gerber, MA. Regarding “antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders”. Biol Psychiatry. 2005;58:916.
116.Budman, C, Coffey, B, Dure, L, et al.Regarding “antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders”. Biol Psychiatry. 2005;58:917.
117.Perlmutter, SJ, Leitman, SF, Garvey, MA, et al.Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999;354:1153–1158.
118.Baer, L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry. 1994;55:18–23.
119.Leckman, JF, Grice, DE, Boardman, J, et al.Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154:911–917.
120.Mataix-Cols, D, Rauch, SL, Manzo, PA, Jenike, MA, Baer, L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409–1416.
121.Mataix-Cols, D, Baer, L, Rauch, SL, Jenike, MA. Relation of factor-analysed symptom dimensions of obsessive-compulsive disorder to personality disorders. Acta Psychiatr Scand 2000;102:199–202.
122.Summerfeldt, LJ, Kloosterman, PH, Anthony, MM, Richter, MA, Swinson, RP. The relationship between miscellaneous symptoms and major symptom factors in obsessive-compulsive disorder. Behav Res Ther. 2004;42:1453–1467.
123.Mataix-Cols, D, Marks, IM, Greist, JH, Kobak, KA, Baer, L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom. 2002;71:255–262.
124.Tek, C, Ulug, B. Religiosity and religious obsessions in obsessive-compulsive disorder. Psychiatry Res. 2001;104:99–108.
125.Cavallini, MC, Di Bella, D, Siliprandi, F, Malchiodi, F, Bellodi, L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet. 2002;114:347–353.
126.Foa, EB, Huppert, JD, Leiberg, S, et al.The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002;14:485–496.
127.Feinstein, SB, Fallon, BA, Petkova, E, Leibowitz, MR. Item-by-item factor analysis of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci. 2003;15:187–193.
128.Leckman, JF, Pauls, DL, Zhang, H, et al.Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gillesde la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet. 2003;116:60–68.
129.Denys, D, de Geus, F, van Megen, HJ, Westenberg, HG. Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res. 2004;128:273–280.
130.Denys, D, de Geus, F, van Megen, HJ, Westenberg, HG. Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician–rated scale and self-report measure. Psycopathology. 2004;37:181–189.
131.Hasler, G, LaSalle-Ricci, VH, Ronquillo, JG, et al.Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res. 2005;135:121–132.
132.Hasler, G, Kazuba, D, Murphy, DL. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2006;141:403–408.
133.Delorme, R, Bille, A, Betancur, C, et al.Exploratory analyses of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study. BMC Psychiatry. 2006;6:1.
134.Fontenelle, LF, Mendlowicz, MV, Soares, ID, Versiani, M. Patients with obsessive-compulsive disorder and hoarding symptoms: a distinct clinical subtype? Compr Psychiatry. 2004;45:375–383.
135.Greenberg, D. Compulsive hoarding. Am J Psychother. 1987;41:409–416.
136.Frost, RO, Gross, RC. The hoarding of possessions. Behav Res Ther. 1993;31:367–381.
137.Frost, RO, Steketee, G, Williams, L. Hoarding: a community health problem. Health Soc Care Community. 2000;8:229–234.
138.Alsobrook, JP II, Leckman, JF, Goodman, WK, Rasmussen, SA, Pauls, DL. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet. 1999;88:669–675.
139.Hasler, G, Pinto, A, Benjamin, DG, et al.Familiality of Factor Analysis-derived YBOCS Dimensions in OCD Affected Sibling Pairs from the OCD Collaborative Genetics Study. Biol Psychiatry. In press.
140.Zhang, H, Leckman, JF, Pauls, DL, et al.Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet. 2002;70:896–904.
141.Pujol, J, Soriano-Mas, C, Alonso, P, et al.Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61:720–730.
142.Valente, AA Jr, Miguel, EC, Castro, CC, et al.Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry. 2005;58:479–487.
143.Saxena, S, Brody, AL, Maidment, KM, et al.Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry. 2004;161:1038–1048.
144.Phillips, ML, Marks, IM, Senior, C, et al.A differential neural response in obsessive-compulsive patients with washing compared with checking symptoms to disgust. Psychol Med. 2000;30:1037–1050.
145.Schienle, A, Schafer, A, Stark, R, Walter, B, Vaitl, D. Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiol. 2005;57:69–77.
146.Shapira, NA, Liu, Y, He, AG, et al.Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry. 2003;54:751–756.
147.Mataix-Cols, D, Wooderson, S, Lawrence, N, Brammer, MJ, Speckens, A, Phillips, ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61:564–576.
148.Winsber, ME, Cassic, KS, Koran, LM. Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry. 1999;60:591–597.
149.Abramowitz, JS, Franklin, ME, Schwartz, SA, Furr, JM. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol. 2003;71:1049–1057.
150.Black, DW, Monahan, P, Gable, J, Blum, N, Clancy, G, Baker, P. Hoarding and treatment response in 38 nondepressed subjects with obesssive-compulsive disorder. J Clin Psychiatry. 1998;59:420–425.
151.Saxena, S, Maidment, KM, Vapnik, T, et al.Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry. 2002;63:21–27.
152.Saxena, S, Maidment, KM. Treatment of compulsive hoarding. J Clin Psychol. 2004;60:1143–1154.
153.Fullana, MA, Mataix-Cols, D, Caseras, X, et al.High sensitivity to punishment and low impulsivity in obsessive-compulsive patients with hoarding symptoms. Psychiatry Res. 2004;129:21–27.
154.Steketee, G, Frost, RO, Wincze, J, Greene, K, Douglass, H. Group and individual treatment of compulsive hoarding: A pilot study. Behavioral and Cognitive Psychotherapy. 2000;28:259–268.
155.Hollander, E, Kwon, JH, Stein, DJ, Broatch, J, Rowland, CT, Himelein, CA. Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry. 1996;57:3–6.
156.Leonard, HL, Lenane, MC, Swedo, SE, Rettew, DC, Gershon, ES, Rapoport, JL. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry. 1992;149:1244–1251.
157.Rasmussem, SA, Tsuang, MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry. 1986;143:317–322.
158.Karno, M, Golding, JM, Sorenson, SB, Burnam, MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094–1099.
159.Crino, RD, Andrews, G. Personality disorder in obsessive compulsive disorder: a controlled study. J Psychiatr Res. 1996;30:29–38.
160.Nestadt, G, Samuels, J, Riddle, MA, et al.The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med. 2001;31:481–487.
161.Leonard, HL, Lenane, MC, Swedo, SE, Rettew, DC, Rapoport, JL. A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry. 1991;48:821–827.
162.Bienvenu, OJ, Samuels, JF, Riddle, MA, et al.The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000;48:287–293.
163.Hollander, E, Liebowitz, MR, Winchel, R, Klumker, A, Klein, DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry. 1989;146:768–770.
164.Gonzales, CH. Estudo de familias no transtorno obsessivo-compulsivo. [dissertation]. Sao Paulo, Brazil: Escola Paulista de Medicina/Universidade Federal de São Paulo: 2003.
165.Lochner, C, Hemmings, SM, Kinnear, CJ, et al.Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry. 2005;46:14–19.
166.Nestadt, G, Addington, A, Samuels, J, et al.The identification of OCD-related subgroups based on comorbidity. Biol Psychiatry. 2003;53:914–920.
167.Chacon, P, Rosario-Campos, MC, Hounie, AG, Lopes, AC, Curi, M, Miguel, EC. Comment on “the identification of OCD-related subgroups based on comorbidity”. Biol Psychiatry. 2004;55:960.
168.Kendell, RE. Clinical validity. Psychol Med. 1989;19:45–55.
169.Gottesman, II, Gould, TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–645.
170.Hasler, G, Drevets, WC, Manji, HK, Charney, DS. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004;29:1765–1781.
171.Hasler, G, Drevets, WC, Gould, TD, Gottesman, II, Manji, HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry. 2006;60:93–105.
172.Savage, CR, Baer, L, Keuthen, NJ, Brown, HD, Rauch, SL, Jenike, MA. Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry. 1999;45:905–916.
173.Bechara, A, Damasio, AR, Damasio, H, Anderson, SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15.
174.Freedman, M. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease. Brain Cogn. 1990;14:134–143.
175.Rosenberg, DR, Averbach, DH, O'Hearn, KM, Seymour, AB, Birmaher, B, Sweeney, JA. Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder. Arch Gen Psychiatry. 1997;54:831–838.
176.Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005;29:399–419.
177.Brambilla, P, Barale, F, Caverzasi, E, Soares, JC. Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psichiatr Soc. 2002;11:88–99.
178.Gottesman, II, Hanson, DR. Human development: biological and genetic processes. Annu Rev Psychol. 2004;56:263–286.
179.Rosario-Campos, MC, Miguel, EC, Quatrano, S, et al.The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry. 2006;11:495–504.